Quimno, Gomercindo B.
HRN: 25-28-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/22/2025
01/28/2025
IV
2.25 Grams
Q 8 Hours
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes